Gavazza, A.; Maggiori, A.; Biagini, L.; Fruganti, A.; Domenech, O.; Arletti, D.; Muollo, M.C.; Masci, C.; Rossi, G.
Clinical Value of Serum Cardiac Troponin I, Trimethylamine N-Oxide (TMAO), and Galectin-3 in Canine Myxomatous Mitral Valve Degeneration: A Preliminary Study. Vet. Sci. 2026, 13, 335.
https://doi.org/10.3390/vetsci13040335
AMA Style
Gavazza A, Maggiori A, Biagini L, Fruganti A, Domenech O, Arletti D, Muollo MC, Masci C, Rossi G.
Clinical Value of Serum Cardiac Troponin I, Trimethylamine N-Oxide (TMAO), and Galectin-3 in Canine Myxomatous Mitral Valve Degeneration: A Preliminary Study. Veterinary Sciences. 2026; 13(4):335.
https://doi.org/10.3390/vetsci13040335
Chicago/Turabian Style
Gavazza, Alessandra, Andrea Maggiori, Lucia Biagini, Alessandro Fruganti, Oriol Domenech, Dalida Arletti, Maria Chiara Muollo, Chiara Masci, and Giacomo Rossi.
2026. "Clinical Value of Serum Cardiac Troponin I, Trimethylamine N-Oxide (TMAO), and Galectin-3 in Canine Myxomatous Mitral Valve Degeneration: A Preliminary Study" Veterinary Sciences 13, no. 4: 335.
https://doi.org/10.3390/vetsci13040335
APA Style
Gavazza, A., Maggiori, A., Biagini, L., Fruganti, A., Domenech, O., Arletti, D., Muollo, M. C., Masci, C., & Rossi, G.
(2026). Clinical Value of Serum Cardiac Troponin I, Trimethylamine N-Oxide (TMAO), and Galectin-3 in Canine Myxomatous Mitral Valve Degeneration: A Preliminary Study. Veterinary Sciences, 13(4), 335.
https://doi.org/10.3390/vetsci13040335
